TT vs VIR · P/E 36, rev $21.32B vs rev $74.2M
Trane Technologies plc (TT) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Latest reported VIR revenue for 2024-12-31 was $74.2M. Net income was -$522.0M. Revenue was down 13.9% from 2023-12-31 to 2024-12-31. VIR currently screens at market cap $1.45B.
TT currently screens at market cap $104.45B and trailing P/E 36.2. VIR currently screens at market cap $1.45B.
Not investment advice. Open the TT and VIR stock pages for the full models.
Not investment advice.